Inactive Instrument

News Immunomedics, Inc.

Equities

IMMU

US4529071080

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves	23-03-27	AQ
Everest Medicines Limited announced that it has received $280 million in funding from Immunomedics, Inc.	23-03-26	CI
Gilead to Acquire Remaining Worldwide Rights of Trodelvy	22-08-16	AQ
Protara Therapeutics : Announces Appointment of Martin Sebastian Olivo, M.D. as Chief Medical Officer	21-04-20	AQ
Gilead Sciences : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020	21-01-11	DJ
Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer	20-12-11	AQ
Gilead Sciences : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany	20-12-10	DJ
Gilead Sciences : Announces Third Quarter 2020 Financial Results	20-10-29	AQ
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales -- Update	20-10-28	DJ
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales	20-10-28	DJ
Gilead Sciences : Completes Acquisition of Immunomedics, Inc.	20-10-26	AQ
IMMUNOMEDICS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-10-23	AQ
Immunomedics, Inc. Announces Board Changes	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Biotechnology Select Industry Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Global BMI Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P TMI Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Midcap Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Growth Index	20-10-23	CI
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Midcap Growth Index	20-10-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Immunomedics, Inc.

Equities

IMMU

US4529071080

Summary

Filters